Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Peariso, Katrina L.
24  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Factors associated with long-term outcomes in pediatric ref..:

Gainza Lein, Marina Andrea ; Barcia Aguilar, Cristina ; Piantino, Juan...
Epilepsia 2021;62:2190–2204..  , 2021
Link: https://doi.org/10.1111/..
 
?
2

Benzodiazepine administration patterns before escalation to..:

Sheehan, Theodore ; Amengual‐Gual, Marta ; Vasquez, Alejandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292193/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
3

Clinical presentation of new onset refractory status epilep..:

Sculier, Claudine ; Barcia Aguilar, Cristina ; Gaspard, Nicolas...
uri/info:doi/10.1111/epi.16950.  , 2021
Link: http://hdl.handle.net/20..
 
?
4

Clinical presentation of new onset refractory status epilep..:

Sculier, Claudine ; Aguilar, Cristina Barcia ; Gaspard, Nicolas...
Epilepsia. 2021;62:1629–1642..  , 2021
Link: https://doi.org/10.1111/..
 
?
5

Factors associated with long‐term outcomes in pediatric ref..:

Gaínza‐Lein, Marina ; Barcia Aguilar, Cristina ; Piantino, Juan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291041/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Clinical presentation of new onset refractory status epilep..:

Sculier, Claudine ; Barcia Aguilar, Cristina ; Gaspard, Nicolas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362203/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Association of guideline publication and delays to treatmen..:

Sánchez Fernández, Iván ; Abend, Nicholas S ; Amengual Gual, Marta...
Neurology® 2020;95:e1222-e1235.  , 2020
Link: https://doi.org/10.1212/..
 
?
8

Association of guideline publication and delays to treatmen..:

Sánchez Fernández, Iván ; Abend, Nicholas S ; Amengual-Gual, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538224/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

First-line medication dosing in pediatric refractory status..:

Vasquez, Alejandra ; Gaínza-Lein, Marina ; Abend, Nicholas S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713738/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

KCTD7 deficiency defines a distinct neurodegenerative disor..:

Metz, Kyle A ; Teng, Xinchen ; Coppens, Isabelle...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ana.25351.  , 2018
Link: https://hal.archives-ouv..
 
?
11

KCTD7 deficiency defines a distinct neurodegenerative disor..:

Metz, Kyle A ; Teng, Xinchen ; Coppens, Isabelle...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ana.25351.  , 2018
Link: https://hal.science/hal-..
 
?
12

KCTD7 deficiency defines a distinct neurodegenerative disor..:

Metz, Kyle A ; Teng, Xinchen ; Coppens, Isabelle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295419/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
13

Association of Time to Treatment With Short-term Outcomes f..:

Gaínza-Lein, Marina ; Sánchez Fernández, Iván ; Jackson, Michele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885266/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
14

KCTD7 deficiency defines a distinct neurodegenerative disor..:

Metz, Kyle A ; Teng, Xinchen ; Coppens, Isabelle...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ana.25351.  , 2018
Link: https://hal.science/hal-..
 
?
15

KCTD7 deficiency defines a distinct neurodegenerative disor..:

Metz, Kyle A ; Teng, Xinchen ; Coppens, Isabelle...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ana.25351.  , 2018
Link: https://hal.science/hal-..
 
1-15